tiprankstipranks
QuidelOrtho initiated with an Outperform at RBC Capital
The Fly

QuidelOrtho initiated with an Outperform at RBC Capital

RBC Capital analyst Conor McNamara initiated coverage of QuidelOrtho with an Outperform rating and $125 price target. The analyst believes the company will emerge from the pandemic with a much more diverse product and geographic presence, higher market share in more valuable end markets, and accelerated development and go-to-market plans with key product launches. He sees more sustainable growth and margin expansion opportunities for QuidelOrtho post pandemic.

Published first on TheFly

See the top stocks recommended by analysts >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles